{"id":"https://openalex.org/W2276491111","doi":"https://doi.org/10.1021/acs.oprd.5b00369","title":"Case Studies Illustrating a Science and Risk-Based Approach to Ensuring Drug Quality When Using Enzymes in the Manufacture of Active Pharmaceuticals Ingredients for Oral Dosage Form","display_name":"Case Studies Illustrating a Science and Risk-Based Approach to Ensuring Drug Quality When Using Enzymes in the Manufacture of Active Pharmaceuticals Ingredients for Oral Dosage Form","publication_year":2016,"publication_date":"2016-02-09","ids":{"openalex":"https://openalex.org/W2276491111","doi":"https://doi.org/10.1021/acs.oprd.5b00369","mag":"2276491111"},"language":"en","primary_location":{"id":"doi:10.1021/acs.oprd.5b00369","doi":"https://doi.org/10.1021/acs.oprd.5b00369","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.oprd.5b00369","pdf_url":null,"source":{"id":"https://openalex.org/S107255770","display_name":"Organic Process Research & Development","issn_l":"1083-6160","issn":["1083-6160","1520-586X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Process Research & Development","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050260763","display_name":"Andrew S. Wells","orcid":"https://orcid.org/0000-0003-0832-2410","observed_orcids":["https://orcid.org/0000-0003-0832-2410"]},"institutions":[{"id":"https://openalex.org/I2800623009","display_name":"Quorn (United Kingdom)","ror":"https://ror.org/00vgcn396","country_code":"GB","type":"company","lineage":["https://openalex.org/I2800623009"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Andrew S. Wells","raw_affiliation_strings":["Charnwood Technical Consulting Ltd., Parklands, 24 Northage Close, Quorn, Leicestershire, LE12 8AT, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charnwood Technical Consulting Ltd., Parklands, 24 Northage Close, Quorn, Leicestershire, LE12 8AT, United Kingdom","institution_ids":["https://openalex.org/I2800623009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109126905","display_name":"John W. Wong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John W. Wong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061618248","display_name":"Peter C. Michels","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36344538","display_name":"Albany Molecular Research (United States)","ror":"https://ror.org/03y76pe29","country_code":"US","type":"company","lineage":["https://openalex.org/I36344538"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter C. Michels","raw_affiliation_strings":["AMRI Inc., Department of Chemical Development, Fermentation and Biotransformations, 21 Corporate Circle, Albany, New York 12203, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AMRI Inc., Department of Chemical Development, Fermentation and Biotransformations, 21 Corporate Circle, Albany, New York 12203, United States","institution_ids":["https://openalex.org/I36344538"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080990349","display_name":"David A. Entwistle","orcid":"https://orcid.org/0000-0001-6268-1399","observed_orcids":["https://orcid.org/0000-0001-6268-1399"]},"institutions":[{"id":"https://openalex.org/I175381709","display_name":"Codexis (United States)","ror":"https://ror.org/00f76ab84","country_code":"US","type":"company","lineage":["https://openalex.org/I175381709"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Entwistle","raw_affiliation_strings":["Codexis Inc., 200 Penobscot Drive, Redwood City, California 94063, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Codexis Inc., 200 Penobscot Drive, Redwood City, California 94063, United States","institution_ids":["https://openalex.org/I175381709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008903933","display_name":"Keith R. Fandrick","orcid":"https://orcid.org/0000-0003-4875-3143","observed_orcids":["https://orcid.org/0000-0003-4875-3143"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith Fandrick","raw_affiliation_strings":["Boehringer-Ingelheim Pharmaceuticals Inc., Chemical Development, 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer-Ingelheim Pharmaceuticals Inc., Chemical Development, 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076767090","display_name":"Gregory L. Finch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gregory L. Finch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029726570","display_name":"Animesh Goswami","orcid":"https://orcid.org/0000-0001-8580-9922","observed_orcids":["https://orcid.org/0000-0001-8580-9922"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Animesh Goswami","raw_affiliation_strings":["Bristol-Myers Squibb, Research & Development, One Squibb Drive, New Brunswick, New Jersey 08903, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Research & Development, One Squibb Drive, New Brunswick, New Jersey 08903, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107906793","display_name":"Heewon Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heewon Lee","raw_affiliation_strings":["Boehringer-Ingelheim Pharmaceuticals Inc., Chemical Development, 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer-Ingelheim Pharmaceuticals Inc., Chemical Development, 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002981482","display_name":"Stefan Mix","orcid":"https://orcid.org/0000-0002-4643-5849","observed_orcids":["https://orcid.org/0000-0002-4643-5849"]},"institutions":[{"id":"https://openalex.org/I4210137931","display_name":"Almac (United Kingdom)","ror":"https://ror.org/03prym056","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210137931"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stefan Mix","raw_affiliation_strings":["Almac, Department of Biocatalysis and Isotope Chemistry, 20 Seagoe Industrial Estate, Craigavon BT63 5QD, Northern Ireland United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almac, Department of Biocatalysis and Isotope Chemistry, 20 Seagoe Industrial Estate, Craigavon BT63 5QD, Northern Ireland United Kingdom","institution_ids":["https://openalex.org/I4210137931"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078486903","display_name":"Thomas S. Moody","orcid":"https://orcid.org/0000-0002-8266-0269","observed_orcids":["https://orcid.org/0000-0002-8266-0269"]},"institutions":[{"id":"https://openalex.org/I4210137931","display_name":"Almac (United Kingdom)","ror":"https://ror.org/03prym056","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210137931"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Thomas S. Moody","raw_affiliation_strings":["Almac, Department of Biocatalysis and Isotope Chemistry, 20 Seagoe Industrial Estate, Craigavon BT63 5QD, Northern Ireland United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almac, Department of Biocatalysis and Isotope Chemistry, 20 Seagoe Industrial Estate, Craigavon BT63 5QD, Northern Ireland United Kingdom","institution_ids":["https://openalex.org/I4210137931"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Long Pang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I175381709","display_name":"Codexis (United States)","ror":"https://ror.org/00f76ab84","country_code":"US","type":"company","lineage":["https://openalex.org/I175381709"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Long Pang","raw_affiliation_strings":["Codexis Inc., 200 Penobscot Drive, Redwood City, California 94063, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Codexis Inc., 200 Penobscot Drive, Redwood City, California 94063, United States","institution_ids":["https://openalex.org/I175381709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064580810","display_name":"Robert K. Sato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I175381709","display_name":"Codexis (United States)","ror":"https://ror.org/00f76ab84","country_code":"US","type":"company","lineage":["https://openalex.org/I175381709"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert K. Sato","raw_affiliation_strings":["Codexis Inc., 200 Penobscot Drive, Redwood City, California 94063, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Codexis Inc., 200 Penobscot Drive, Redwood City, California 94063, United States","institution_ids":["https://openalex.org/I175381709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073735499","display_name":"Nicholas John Turner","orcid":"https://orcid.org/0000-0002-8708-0781","observed_orcids":["https://orcid.org/0000-0002-8708-0781","https://orcid.org/0000-0001-8937-0873"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicholas J. Turner","raw_affiliation_strings":["School of Chemistry, Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Chemistry, Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"last","author":{"id":null,"display_name":"Timothy J. Watson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy J. Watson","raw_affiliation_strings":["\u2225 Pharmaceutical Sciences Chemical R&D, \u22a5 Drug Safety R&D, \u2207 Pharmaceutical Sciences, Global CMC Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2225 Pharmaceutical Sciences Chemical R&D, \u22a5 Drug Safety R&D, \u2207 Pharmaceutical Sciences, Global CMC Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5050260763"],"corresponding_institution_ids":["https://openalex.org/I2800623009"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.1227,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.74926577,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"20","issue":"3","first_page":"594","last_page":"601"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10404","display_name":"Enzyme Catalysis and Immobilization","score":0.9320999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10404","display_name":"Enzyme Catalysis and Immobilization","score":0.9320999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13180","display_name":"Chemistry and Chemical Engineering","score":0.02019999921321869,"subfield":{"id":"https://openalex.org/subfields/2304","display_name":"Environmental Chemistry"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11617","display_name":"Enzyme Production and Characterization","score":0.018200000748038292,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biocatalysis","display_name":"biocatalysis","score":0.9909999966621399},{"id":"https://openalex.org/keywords/active-pharmaceutical-ingredients","display_name":"active pharmaceutical ingredients","score":0.8080000281333923},{"id":"https://openalex.org/keywords/drug-quality","display_name":"drug quality","score":0.6830000281333923},{"id":"https://openalex.org/keywords/risk-based-approach","display_name":"risk-based approach","score":0.8809999823570251},{"id":"https://openalex.org/keywords/regulatory-guidance","display_name":"regulatory guidelines","score":0.7570000290870667},{"id":"https://openalex.org/keywords/oral-formulations","display_name":"oral dosage forms","score":0.6579999923706055},{"id":"https://openalex.org/keywords/patient-safety","display_name":"patient safety","score":0.5989999771118164},{"id":"https://openalex.org/keywords/regulatory-approval","display_name":"regulatory approval","score":0.5960000157356262},{"id":"https://openalex.org/keywords/enzyme-catalyzed-synthesis","display_name":"enzyme-catalyzed synthesis","score":0.6639999747276306}],"concepts":[{"id":"https://openalex.org/C191503008","wikidata":"https://www.wikidata.org/wiki/Q16007026","display_name":"Biocatalysis","level":4,"score":0.7552740573883057},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.6635543704032898},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.529326856136322},{"id":"https://openalex.org/C4916135","wikidata":"https://www.wikidata.org/wiki/Q4119055","display_name":"Bioprocess","level":2,"score":0.5122169852256775},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.4887804687023163},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.473501980304718},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4497213661670685},{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.425346702337265},{"id":"https://openalex.org/C204320433","wikidata":"https://www.wikidata.org/wiki/Q7268772","display_name":"Quality by Design","level":3,"score":0.41955435276031494},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.416675865650177},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.35229992866516113},{"id":"https://openalex.org/C539667460","wikidata":"https://www.wikidata.org/wiki/Q2414942","display_name":"Management science","level":1,"score":0.32809412479400635},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.27337411046028137},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.22898566722869873},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.22649329900741577},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17603909969329834},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.13244393467903137},{"id":"https://openalex.org/C19351080","wikidata":"https://www.wikidata.org/wiki/Q1395034","display_name":"New product development","level":2,"score":0.11545777320861816},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.09618565440177917},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.09520399570465088},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C154881586","wikidata":"https://www.wikidata.org/wiki/Q898579","display_name":"Ionic liquid","level":3,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.oprd.5b00369","doi":"https://doi.org/10.1021/acs.oprd.5b00369","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.oprd.5b00369","pdf_url":null,"source":{"id":"https://openalex.org/S107255770","display_name":"Organic Process Research & Development","issn_l":"1083-6160","issn":["1083-6160","1520-586X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Process Research & Development","raw_type":"journal-article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/7cfb2cbd-58ad-45db-98af-cf0f9de127ca","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/7cfb2cbd-58ad-45db-98af-cf0f9de127ca","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Turner, N, Wells, A, Wong, J W, Michels, P C, Fandrick, K, Finch, G L, Goswami, A, Lee, H, Mix, S, Moody, T, Pang, L, Entwistle, D A, Sato, R K & Watson, T J 2016, 'Case Studies Illustrating a Science and Risk-Based Approach to Ensuring Drug Quality When Using Enzymes in the Manufacture of Active Pharmaceuticals Ingredients for Oral Dosage Form', Organic Process Research & Development, vol. 20, no. 3, pp. 3298-3306. https://doi.org/10.1021/acs.oprd.5b00369","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.504800021648407,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7685031107","display_name":null,"funder_award_id":"115360","funder_id":"https://openalex.org/F4320334960","funder_display_name":"Seventh Framework Programme"}],"funders":[{"id":"https://openalex.org/F4320314178","display_name":"European Federation of Pharmaceutical Industries and Associations","ror":"https://ror.org/00g1x4v36"},{"id":"https://openalex.org/F4320334960","display_name":"Seventh Framework Programme","ror":"https://ror.org/00k4n6c32"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W63719655","https://openalex.org/W611993896","https://openalex.org/W1946747292","https://openalex.org/W1969492379","https://openalex.org/W1976236461","https://openalex.org/W1979652601","https://openalex.org/W1984180361","https://openalex.org/W2043134556","https://openalex.org/W2044066756","https://openalex.org/W2046914949","https://openalex.org/W2047527115","https://openalex.org/W2063968553","https://openalex.org/W2072581462","https://openalex.org/W2079754263","https://openalex.org/W2082420349","https://openalex.org/W2084806900","https://openalex.org/W2137142187","https://openalex.org/W2148424034","https://openalex.org/W2151993730","https://openalex.org/W2159034455","https://openalex.org/W2161863487","https://openalex.org/W2323954531","https://openalex.org/W4232534952","https://openalex.org/W4234557919"],"related_works":["https://openalex.org/W2323954531","https://openalex.org/W3029658473","https://openalex.org/W2951033143","https://openalex.org/W4411146215","https://openalex.org/W4294124895","https://openalex.org/W4400720210","https://openalex.org/W3214882609","https://openalex.org/W7008420129","https://openalex.org/W2900718324","https://openalex.org/W2973890758"],"abstract_inverted_index":{"Biocatalysis":[0],"is":[1,175],"essentially":[2],"the":[3,74,87,104,142,200],"use":[4,69],"of":[5,52,76,89,99,103,136,159,202],"enzymes":[6,41],"to":[7,31,36,68,114,176,184],"perform":[8],"chemical":[9],"transformations":[10],"on":[11,147],"organic":[12],"compounds":[13],"and":[14,28,34,62,80,94,110,118,139,150,162,181,188,191],"has":[15,65,145],"been":[16],"exploited":[17],"for":[18,45,73,91,194,199],"applications":[19],"in":[20,141,164,172],"various":[21],"industries":[22],"including":[23,55],"food,":[24],"fine":[25],"chemicals,":[26],"agrochemicals,":[27],"pharmaceuticals.":[29,205],"Due":[30],"their":[32],"selectivity":[33],"ability":[35],"operate":[37],"under":[38],"mild":[39],"conditions,":[40],"offer":[42],"clear":[43,179],"advantages":[44],"efficient":[46],"sustainable":[47],"manufacturing":[48],"processes.":[49],"Rapid":[50],"development":[51],"enabling":[53],"technologies":[54],"gene":[56],"mining,":[57],"molecular":[58],"biology,":[59],"biocatalyst":[60],"evolution,":[61],"bioprocess":[63],"engineering,":[64],"created":[66],"opportunities":[67],"biocatalysis":[70,90,123,143,196],"more":[71],"broadly":[72],"manufacture":[75,93,201],"small":[77,203],"molecule":[78,204],"intermediates":[79],"APIs":[81],"(active":[82],"pharmaceutical":[83],"ingredients).":[84],"To":[85],"facilitate":[86],"adoption":[88],"API":[92],"address":[95],"a":[96,108,178,186],"perceived":[97],"lack":[98],"regulatory":[100,160],"clarity,":[101],"several":[102],"current":[105],"authors":[106],"published":[107],"science":[109,190],"risk":[111],"based":[112],"approach":[113,193],"ensuring":[115],"patient":[116],"safety":[117],"drug":[119],"quality":[120],"when":[121],"using":[122],"(":[124],"Org.":[125],"Process":[126],"Res.":[127],"Dev.":[128],"2012,":[129],"16,":[130],"1986\u22121993).":[131],"Since":[132],"this":[133,165,173],"publication,":[134],"consultation":[135],"multiple":[137],"users":[138],"stakeholders":[140],"community":[144],"expanded":[146],"key":[148],"guidance":[149],"specific":[151],"approaches,":[152],"as":[153,155,170],"well":[154],"providing":[156],"real":[157],"examples":[158],"review":[161],"approval":[163],"article.":[166],"Our":[167],"ultimate":[168],"goal":[169],"highlighted":[171],"publication":[174],"provide":[177],"path":[180],"knowledge":[182],"base":[183],"enable":[185],"robust":[187],"sound":[189],"risk-based":[192],"utilizing":[195],"whenever":[197],"appropriate":[198]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}